Northwestern Mutual Wealth Management
ADMA icon

Northwestern Mutual Wealth Management’s ADMA Biologics ADMA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22K Sell
246
-232
-49% -$3.66K ﹤0.01% 3569
2025
Q4 		$8.72K Buy
+478
New +$8.06K ﹤0.01% 3043

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northwestern Mutual Wealth Management's ADMA Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its ADMA Biologics (ADMA) stake by 49% in Q1 2026, selling an estimated $3.66K and leaving 246 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Northwestern Mutual Wealth Management first reported a position in ADMA in Q4 2025 and has held it in 2 quarters since. The position peaked at $8.72K in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Northwestern Mutual Wealth Management held 246 shares of ADMA Biologics worth $2.22K as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 232 ADMA Biologics shares in Q1 2026, an estimated $3.66K.
  • ADMA Biologics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3569 holding.
  • Northwestern Mutual Wealth Management first reported a position in ADMA Biologics in Q4 2025 and has held it in 2 quarters since.
  • Northwestern Mutual Wealth Management's ADMA Biologics position peaked at $8.72K in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.